INS and breast carcinoma: Several observational epidemiological studies have demonstrated that high levels of endogenous insulin are associated with higher risk of cancer incidence and mortality, including risk of colorectal [65], endometrial [66, 67], prostate [68] and breast cancer [69, 70] and breast cancer mortality [71].